John C Somberg
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$462KFederal grants as PI3 awards
1Patents grantedLatest Aug 20, 2013
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $462K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 11, 2019 | NIH | SBIR Phase I Soestolol: A potentially short acting Type III anti-arrhythmic | $153K | ACADEMIC PHARMACEUTICALS |
| May 28, 2019 | NIH | SBIR Phase I Developing a Parenteral Formulation of Metolazone | $158K | ACADEMIC PHARMACEUTICALS |
| Sep 13, 2017 | NIH | SBIR Phase I A Safer Cardiac, Abuse Deterrent Formulation of Methadone | $150K | ACADEMIC PHARMACEUTICALS |
1 patents as inventor
- US 8513278ACADEMIC PHARMACEUTICALSAug 20, 2013
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,480
Awards as PI#822
Patents#155
Companies
- ACADEMIC PHARMACEUTICALSLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.